Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studiesResearch in context

Summary: Background: Assessing the burden of antimicrobial resistance is essential to determine the magnitude of this problem and to set its priority. We aimed to estimate the burden of disease caused by multidrug-resistant microorganisms (MDRO) in hospitalised patients in Spain. Methods: Three pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Germán Peñalva, Rafael Cantón, María Teresa Pérez-Rodríguez, Juan José González-López, Jesús Rodríguez-Baño, Ester del Barrio-Tofiño, Cristina Kirkegaard-Biosca, Isabel Sánchez-Romero, Andrea Gutiérrez-Villanueva, Teresa Marrodán-Ciordia, José Manuel Guerra-Laso, Cristóbal del Rosario-Quintana, Laura Suárez-Hormiga, Jordi Cámara, Mireia Puig-Asensio, Eva Heredero, María Antonia Sepúlveda, Juan Carlos Rodríguez-Díaz, Esperanza Merino, Emilia Cercenado, Sofia de la Villa, María Siller, Francisco Arnaiz, Cristina Seral, José Antonio Lepe, José Miguel Cisneros, José Ramón Paño-Pardo
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:The Lancet Regional Health. Europe
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776225000122
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576399956770816
author Germán Peñalva
Rafael Cantón
María Teresa Pérez-Rodríguez
Juan José González-López
Jesús Rodríguez-Baño
Ester del Barrio-Tofiño
Cristina Kirkegaard-Biosca
Isabel Sánchez-Romero
Andrea Gutiérrez-Villanueva
Teresa Marrodán-Ciordia
José Manuel Guerra-Laso
Cristóbal del Rosario-Quintana
Laura Suárez-Hormiga
Jordi Cámara
Mireia Puig-Asensio
Eva Heredero
María Antonia Sepúlveda
Juan Carlos Rodríguez-Díaz
Esperanza Merino
Emilia Cercenado
Sofia de la Villa
María Siller
Francisco Arnaiz
Cristina Seral
José Antonio Lepe
José Miguel Cisneros
José Ramón Paño-Pardo
author_facet Germán Peñalva
Rafael Cantón
María Teresa Pérez-Rodríguez
Juan José González-López
Jesús Rodríguez-Baño
Ester del Barrio-Tofiño
Cristina Kirkegaard-Biosca
Isabel Sánchez-Romero
Andrea Gutiérrez-Villanueva
Teresa Marrodán-Ciordia
José Manuel Guerra-Laso
Cristóbal del Rosario-Quintana
Laura Suárez-Hormiga
Jordi Cámara
Mireia Puig-Asensio
Eva Heredero
María Antonia Sepúlveda
Juan Carlos Rodríguez-Díaz
Esperanza Merino
Emilia Cercenado
Sofia de la Villa
María Siller
Francisco Arnaiz
Cristina Seral
José Antonio Lepe
José Miguel Cisneros
José Ramón Paño-Pardo
author_sort Germán Peñalva
collection DOAJ
description Summary: Background: Assessing the burden of antimicrobial resistance is essential to determine the magnitude of this problem and to set its priority. We aimed to estimate the burden of disease caused by multidrug-resistant microorganisms (MDRO) in hospitalised patients in Spain. Methods: Three prospective nationwide studies were conducted in 2018, 2019 and 2023. All patients with a new diagnosis of infection with any of 10 selected MDROs plus Clostridioides difficile during the study period (one week in 2018 and 2019 and two weeks in 2023) were included. Patient demographic, and clinical outcomes were analysed, including incidence, crude all-cause 30-day mortality and years of life lost (YLL). These results were used to calculate weighted and seasonally adjusted annual estimates for the whole country. Findings: In total, 82, 133 and 130 centres participated in the study in 2018, 2019 and 2023, respectively, recording a total of 907, 1392 and 2351 MDRO infections, representing a weighted incidence density of 3.54 (95% CI 2.92–4.17), 5.01 (3.95–6.07), and 4.41 (3.55–5.27) cases/1000 stays, respectively. A total of 161, 198 and 352 patients died with an MDRO infection, representing a weighted incidence density of 0.46 (0.16–0.76), 0.43 (0.17–0.69), and 0.62 (0.52–0.72) deaths/1000 stays, respectively. Based on these data, a nationwide occurrence of 155,294 MDRO infections (95% CI 127,928–182,569) with 20,065 deaths (6938–32,958) was estimated for 2018, 210,451 MDRO infections (165,963–254,975) with 17,982 deaths (7071–28,700) for 2019, and 173,653 MDRO infections (139,814–207258) with 24,582 deaths (20,461–28,796) for 2023. Interpretation: The burden of disease caused by MDRO infections among hospitalised patients in Spain is very high and remains stable over the study period. National actions to combat bacterial resistance need to be intensified. Funding: The management costs of this study were funded by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Researchers have participated voluntarily and none of the investigators received funding for conducting the study.
format Article
id doaj-art-3fdef49020c94ae49c1aa095f9743a07
institution Kabale University
issn 2666-7762
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Europe
spelling doaj-art-3fdef49020c94ae49c1aa095f9743a072025-01-31T05:12:32ZengElsevierThe Lancet Regional Health. Europe2666-77622025-04-0151101220Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studiesResearch in contextGermán Peñalva0Rafael Cantón1María Teresa Pérez-Rodríguez2Juan José González-López3Jesús Rodríguez-Baño4Ester del Barrio-Tofiño5Cristina Kirkegaard-Biosca6Isabel Sánchez-Romero7Andrea Gutiérrez-Villanueva8Teresa Marrodán-Ciordia9José Manuel Guerra-Laso10Cristóbal del Rosario-Quintana11Laura Suárez-Hormiga12Jordi Cámara13Mireia Puig-Asensio14Eva Heredero15María Antonia Sepúlveda16Juan Carlos Rodríguez-Díaz17Esperanza Merino18Emilia Cercenado19Sofia de la Villa20María Siller21Francisco Arnaiz22Cristina Seral23José Antonio Lepe24José Miguel Cisneros25José Ramón Paño-Pardo26Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, SpainCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, SpainHospital Álvaro Cunqueiro, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), Vigo (Pontevedra), Spain; Healthcare Associated Infections Study Group (GEIRAS), Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), Madrid, SpainCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain; Antimicrobial Resistance and Mechanisms of Action Study Group (GEMARA), Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), Madrid, SpainCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen Macarena, CSIC/Universidad de Sevilla, Departamento de Medicina, Universidad de Sevilla, Seville, SpainHospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, SpainHospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, SpainInstituto de Investigación Sanitaria Puerta de Hierro – Segovia de Arana, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, SpainInstituto de Investigación Sanitaria Puerta de Hierro – Segovia de Arana, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, SpainComplejo Asistencial Universitario de León, León, SpainComplejo Asistencial Universitario de León, León, SpainHospital Universitario Insular de Gran Canaria, Las Palmas, SpainHospital Universitario Insular de Gran Canaria, Las Palmas, SpainHospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, SpainHospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, SpainComplejo Hospitalario Universitario de Toledo, Toledo, SpainComplejo Hospitalario Universitario de Toledo, Toledo, SpainHospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, SpainHospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, SpainHospital Universitario Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, SpainHospital Universitario Gregorio Marañón, Madrid, SpainHospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, Santander, SpainHospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, Santander, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, SpainInstituto de Investigación Sanitaria Aragón (IIS Aragón), Hospital Clínico Universitario, Universidad de Zaragoza, Zaragoza, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, SpainInstitute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, SpainInstitute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Corresponding author. Department of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, University of Seville, Institute of Biomedicine of Seville, Av. Manuel Siurot, s/n, 41013, Seville, Spain.Instituto de Investigación Sanitaria Aragón (IIS Aragón), Hospital Clínico Universitario, Universidad de Zaragoza, Zaragoza, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, SpainSummary: Background: Assessing the burden of antimicrobial resistance is essential to determine the magnitude of this problem and to set its priority. We aimed to estimate the burden of disease caused by multidrug-resistant microorganisms (MDRO) in hospitalised patients in Spain. Methods: Three prospective nationwide studies were conducted in 2018, 2019 and 2023. All patients with a new diagnosis of infection with any of 10 selected MDROs plus Clostridioides difficile during the study period (one week in 2018 and 2019 and two weeks in 2023) were included. Patient demographic, and clinical outcomes were analysed, including incidence, crude all-cause 30-day mortality and years of life lost (YLL). These results were used to calculate weighted and seasonally adjusted annual estimates for the whole country. Findings: In total, 82, 133 and 130 centres participated in the study in 2018, 2019 and 2023, respectively, recording a total of 907, 1392 and 2351 MDRO infections, representing a weighted incidence density of 3.54 (95% CI 2.92–4.17), 5.01 (3.95–6.07), and 4.41 (3.55–5.27) cases/1000 stays, respectively. A total of 161, 198 and 352 patients died with an MDRO infection, representing a weighted incidence density of 0.46 (0.16–0.76), 0.43 (0.17–0.69), and 0.62 (0.52–0.72) deaths/1000 stays, respectively. Based on these data, a nationwide occurrence of 155,294 MDRO infections (95% CI 127,928–182,569) with 20,065 deaths (6938–32,958) was estimated for 2018, 210,451 MDRO infections (165,963–254,975) with 17,982 deaths (7071–28,700) for 2019, and 173,653 MDRO infections (139,814–207258) with 24,582 deaths (20,461–28,796) for 2023. Interpretation: The burden of disease caused by MDRO infections among hospitalised patients in Spain is very high and remains stable over the study period. National actions to combat bacterial resistance need to be intensified. Funding: The management costs of this study were funded by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Researchers have participated voluntarily and none of the investigators received funding for conducting the study.http://www.sciencedirect.com/science/article/pii/S2666776225000122Antimicrobial resistanceInfectionsBurdenHospitalSpain
spellingShingle Germán Peñalva
Rafael Cantón
María Teresa Pérez-Rodríguez
Juan José González-López
Jesús Rodríguez-Baño
Ester del Barrio-Tofiño
Cristina Kirkegaard-Biosca
Isabel Sánchez-Romero
Andrea Gutiérrez-Villanueva
Teresa Marrodán-Ciordia
José Manuel Guerra-Laso
Cristóbal del Rosario-Quintana
Laura Suárez-Hormiga
Jordi Cámara
Mireia Puig-Asensio
Eva Heredero
María Antonia Sepúlveda
Juan Carlos Rodríguez-Díaz
Esperanza Merino
Emilia Cercenado
Sofia de la Villa
María Siller
Francisco Arnaiz
Cristina Seral
José Antonio Lepe
José Miguel Cisneros
José Ramón Paño-Pardo
Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studiesResearch in context
The Lancet Regional Health. Europe
Antimicrobial resistance
Infections
Burden
Hospital
Spain
title Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studiesResearch in context
title_full Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studiesResearch in context
title_fullStr Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studiesResearch in context
title_full_unstemmed Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studiesResearch in context
title_short Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studiesResearch in context
title_sort burden of bacterial antimicrobial resistance among hospitalised patients in spain findings from three nationwide prospective studiesresearch in context
topic Antimicrobial resistance
Infections
Burden
Hospital
Spain
url http://www.sciencedirect.com/science/article/pii/S2666776225000122
work_keys_str_mv AT germanpenalva burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT rafaelcanton burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT mariateresaperezrodriguez burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT juanjosegonzalezlopez burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT jesusrodriguezbano burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT esterdelbarriotofino burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT cristinakirkegaardbiosca burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT isabelsanchezromero burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT andreagutierrezvillanueva burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT teresamarrodanciordia burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT josemanuelguerralaso burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT cristobaldelrosarioquintana burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT laurasuarezhormiga burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT jordicamara burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT mireiapuigasensio burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT evaheredero burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT mariaantoniasepulveda burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT juancarlosrodriguezdiaz burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT esperanzamerino burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT emiliacercenado burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT sofiadelavilla burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT mariasiller burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT franciscoarnaiz burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT cristinaseral burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT joseantoniolepe burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT josemiguelcisneros burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext
AT joseramonpanopardo burdenofbacterialantimicrobialresistanceamonghospitalisedpatientsinspainfindingsfromthreenationwideprospectivestudiesresearchincontext